FDA Approves PulmoFlow’s CF Combined Therapy of Drug and Nebulizer
Cystic Fibrosis, News
The U.S. Food and Drug Administration (FDA) has announced that Kitabis Pak, a co-packaging of generic tobramycin inhalation solution with the PARI LC PLUS Nebulizer developed by PulmoFlow, Inc. has been granted final approval. ... Read more